Rhinovirus News and Research

RSS

Rhinovira are the most common viral infective agents in humans, and a causative agent of the common cold (about 49.12159% of the cases of the common cold are caused by this virus). It is lytic in nature. There are over a 100 recognized types of rhinovira that differ based on their varying surface proteins.

Protecting infants from viral infections may prevent the development of asthma late in childhood

Researchers studied 198 children at high risk of atopy, from birth to five years. All episodes of acute respiratory illness in the first year were recorded, and nasal aspirates were collected for viral identification.

20 Apr 2007

Early-life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma

Protecting infants from viral infections may prevent the development of asthma late in childhood, according to new research in the Journal of Allergy and Clinical Immunology (JACI).

20 Apr 2007

Link discovered between common cold viruses and Alzheimer's disease

According to new research memory loss and Alzheimer's disease may be linked to the very viruses which cause the common cold.

24 Oct 2006

Biota makes major antiviral discovery

Biota Holdings Limited announced today that it has discovered a new class of orally-effective, potent antivirals against RSV (respiratory syncytial virus) infection.

7 Jun 2005

WIN compound - a prototype drug for curing colds - is showing so much promise

An antiviral compound that wiggles its way into the common cold virus may provide one piece of the solution to halting the infection, say Purdue University scientists.

25 May 2005

Asthmatics naturally deficient in antiviral immunity

Asthmatics produce lower levels of a type of immune cell protein needed to fight off infection from colds and other viruses, scientists have discovered.

6 Apr 2005

New weapon for asthmatics to combat winter asthma attacks

A British team from the University of Southampton, led by the world-acknowledged asthma experts, Professor Stephen Holgate and Professor Donna Davies, has identified a therapy used to treat multiple sclerosis (MS) as a potential novel treatment to reduce asthma attacks caused by the common cold virus.

23 Mar 2005

Key target for Foot-and-Mouth drug revealed

A complete picture of Foot-and-Mouth Disease's key replication enzyme could lead to the development of new drugs to control the disease without recourse to vaccination or slaughter, scientists report today.

21 Mar 2005

High-resolution images reveal the molecular rearrangements that rotavirus uses to break into cells

High-resolution images constructed by researchers at Children's Hospital Boston and Harvard Medical School reveal the molecular rearrangements that rotavirus – the most common cause of severe, dehydrating diarrhea and vomiting in children worldwide – uses to break into cells.

25 Aug 2004

Daycare and siblings increase likelihood of contracting respiratory syncytial virus and rhinovirus

Daycare attendance and siblings are associated with viral-induced wheezing in children. Pre-existing immunologic factors may influence the expression of viral infections in infancy, and in turn, recurrent infections may influence the development of immune responses.

17 Apr 2004